Despite the Use of the Combination of G-CSF and Plerixafor for Stem Cell Mobilization, One Third of the Patients with Lymphoma Were Still “Poor Mobilizer” Using the Criteria Recently Proposed by GITMO (< 2.0 X 106 CD 34 + Cells Per Kg in ≤ 3 Apheresis)

✍ Scribed by H.C. Fung; J. Tornatta; B. McLeod; S. Nathan; J. Maciejewski; E. Rich; R. Karmali; A. Jimenez; K.W. Christopherson II; S.A. Gregory

• Book ID: 116282997
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 57 KB
• Volume: 18
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2011.12.175